Henry Schein stock holds near 52-week high as investors focus on 2026 EPS guidance

Published on 09/14/2026 at 14:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Henry Schein stock trades close to its 1-year high, supported by FY 2026 EPS guidance of 5.290 to 5.390 dollars as of September 14, 2026. Analysts see a Moderate Buy consensus with an average price target of 92.93 dollars for Henry Schein stock.

Isometrische 3D-Illustration der Lieferkette von Medizinprodukten von Produktion zu Klinik — Henry Schein US42548G1040 Wertschöpfungskette vom Hersteller über Lager bis zur Zahnarztpraxis isometrisch dargestellt, Illustration mit AI erstellt.

Henry Schein, Inc. stock (ISIN US42548G1040) is trading close to its 1-year high, with shares recently quoted around USD 88.36 on Nasdaq and a 1-year range between USD 61.94 and USD 92.18 as of September 14, 2026, keeping the focus on the company’s earnings power and guidance for fiscal year 2026.

Guidance and earnings expectations in focus

According to MarketBeat on September 14, 2026, Henry Schein has set its guidance for fiscal year 2026 earnings per share at a range of USD 5.290 to USD 5.390, reflecting management’s view of the company’s earnings capacity over the current year.

The same overview from MarketBeat reports that sell-side analysts forecast earnings per share of USD 5.36 for the current fiscal year 2026, placing consensus expectations near the midpoint of the company’s guidance range and giving investors a clear benchmark for performance.

Analyst view and valuation backdrop

According to the analyst summary cited by MarketBeat on September 14, 2026, Henry Schein stock carries a consensus rating of Moderate Buy with an average analyst price target of USD 92.93, suggesting modest upside of about 5.2 percent compared with the USD 88.36 share price level cited in the same report.

The MarketBeat data also highlight that institutional investors own approximately 96.62 percent of the company’s stock as of mid-September 2026, underscoring the strong presence of professional investors in the shareholder base and providing a liquidity backdrop for retail investors who follow Henry Schein stock.

Share performance and market metrics

Per the recent performance figures reported by MarketBeat on September 14, 2026, Henry Schein stock opened at USD 88.36, with a 50-day simple moving average of USD 87.81 and a 200-day simple moving average of USD 80.72, indicating that the shares are trading above both short-term and long-term trend lines.

The market capitalization of Henry Schein is shown at about USD 9.84 billion in a comparative overview from CompaniesMarketCap as of September 12, 2026, placing the company significantly below larger healthcare distributors such as McKesson but in a mid-cap bracket that still attracts broad analyst and institutional attention.

Closing view on Henry Schein stock

As of September 14, 2026, Henry Schein stock around USD 88.36 on Nasdaq sits close to its 1-year high of USD 92.18 and comfortably above the 1-year low of USD 61.94, while investors weigh the fiscal year 2026 EPS guidance range of USD 5.290 to USD 5.390 and a consensus forecast of USD 5.36 per share against an average analyst price target of USD 92.93.